2024-10-30 2025-10-31 2025-10-31 false 16051827 THE ACTING STUDIO LTD 90010Performing arts iso4217:GBP xbrli:pure 160518272024-10-30 160518272025-10-31 160518272024-10-30 2025-10-31 16051827bus:SmallEntities2024-10-30 2025-10-31 16051827bus:AuditExempt-NoAccountantsReport2024-10-30 2025-10-31 16051827bus:FullAccounts2024-10-30 2025-10-31 16051827core:WithinOneYear2025-10-31 16051827core:AfterOneYear2025-10-31 16051827core:WithinOneYear2024-10-30 2025-10-31 16051827core:AfterOneYear2024-10-30 2025-10-31 16051827core:CurrentFinancialInstruments2025-10-31 16051827core:Non-currentFinancialInstruments2025-10-31 16051827core:CurrentFinancialInstruments2024-10-30 2025-10-31 16051827core:Non-currentFinancialInstruments2024-10-30 2025-10-31 16051827core:LandBuildings2024-10-30 2025-10-31 16051827core:FurnitureFittings2024-10-30 2025-10-31 16051827core:OfficeEquipment2024-10-30 2025-10-31 16051827core:Vehicles2024-10-30 2025-10-31 16051827core:PlantMachinery2024-10-30 2025-10-31 16051827core:OtherPropertyPlantEquipment2024-10-30 2025-10-31 16051827core:LandBuildings2025-10-31 16051827core:PlantMachinery2025-10-31 16051827core:Vehicles2025-10-31 16051827core:FurnitureFittings2025-10-31 16051827core:OfficeEquipment2025-10-31 16051827core:OtherPropertyPlantEquipment2025-10-31 16051827core:Right-of-useAssets2024-10-30 2025-10-31 16051827core:Right-of-useAssets2025-10-31 16051827core:Goodwill2024-10-30 2025-10-31 16051827core:PatentsTrademarksLicencesConcessionsSimilar2024-10-30 2025-10-31 16051827core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-10-30 2025-10-31 16051827core:OtherResidualIntangibleAssets2024-10-30 2025-10-31 16051827core:Goodwill2025-10-31 16051827core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-10-31 16051827core:PatentsTrademarksLicencesConcessionsSimilar2025-10-31 16051827core:OtherResidualIntangibleAssets2025-10-31 16051827dpl:CostSales2024-10-30 2025-10-31 16051827dpl:AdministrativeExpenses2024-10-30 2025-10-31 16051827dpl:DistributionCosts2024-10-30 2025-10-3116051827core:ShareCapital2025-10-31 16051827core:SharePremium2025-10-31 16051827core:RevaluationReserve2025-10-31 16051827core:OtherReservesSubtotal2025-10-31 16051827core:ShareCapitalPreferenceShares2025-10-31 16051827core:CapitalRedemptionReserve2025-10-31 16051827core:OtherCapitalReserve2025-10-31 16051827core:RetainedEarningsAccumulatedLosses2025-10-3116051827core:ShareCapital2024-10-30 2025-10-31 16051827core:SharePremium2024-10-30 2025-10-31 16051827core:RevaluationReserve2024-10-30 2025-10-31 16051827core:OtherReservesSubtotal2024-10-30 2025-10-31 16051827core:RetainedEarningsAccumulatedLosses2024-10-30 2025-10-311605182712024-10-30 2025-10-31 1605182722024-10-30 2025-10-3116051827core:ShareCapital12024-10-30 2025-10-31 16051827core:ShareCapital22024-10-30 2025-10-3116051827core:SharePremium12024-10-30 2025-10-31 16051827core:SharePremium22024-10-30 2025-10-3116051827core:RevaluationReserve12024-10-30 2025-10-31 16051827core:RevaluationReserve22024-10-30 2025-10-3116051827core:RetainedEarningsAccumulatedLosses12024-10-30 2025-10-31 16051827core:RetainedEarningsAccumulatedLosses22024-10-30 2025-10-311605182712024-10-30 2025-10-3116051827core:Non-currentFinancialInstrumentscore:CostValuation2024-10-30 16051827core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-31 16051827core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-31 16051827core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-31 16051827core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-10-31 16051827core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3116051827core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-10-30 16051827core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-31 16051827core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-31 16051827core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-31 16051827core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-10-31 16051827core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-31 16051827core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-10-3116051827core:Non-currentFinancialInstruments2025-10-31 16051827core:Non-currentFinancialInstruments2024-10-2916051827bus:Director12024-10-30 2025-10-3116051827bus:PrivateLimitedCompanyLtd2024-10-30 2025-10-31
THE ACTING STUDIO LTD
Unaudited Financial Statements
for the period ended 31 October 2025
Company registration number 16051827
(England and Wales)

Company Information

For the period 30 October 2024 to 31 October 2025
Director Wilson, Nikki Andrea

Registered office 40 York Road
Colwyn Bay
LL29 7EY

Registered number 16051827

Accountant 2020 ACCOUNTANCY
Bourne Space
Bourne House
23 Hinton Road
Bournemouth
Bournemouth
BH1 2EF

Statement of Financial Position

As at 31 October 2025
Notes
2025
£
£
Current assets
Debtors
1
Cash at bank and in hand
4
2,294
2,295
Creditors
Amounts falling due within one year
5
(1,101)
(1,101)
Net current assets (liabilities)
1,194
Total assets less current liabilities
1,194
Net assets (liabilities)
1,194
Capital and reserves
Called up share capital
1
Profit and loss account
1,193
Total equity
1,194

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 30 April 2026 and are signed on its behalf by:

Wilson, Nikki Andrea
Wilson, Nikki Andrea
Director

Company registration number 16051827

Notes to the Financial Statements

For the period 30 October 2024 to 31 October 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

3. Employees

The average number of employees during the year was 0.

4. Cash at bank and in hand

2025
£
Cash at bank
2,294
Total
2,294

5. Creditors due within one year

2025
£
Taxation and social security
501
Accruals and deferred income
600
Total
1,101